Optimal care of lupus nephritis patients.
Optimal care of lupus nephritis patients should include the treatment of proteinuria and hypertension, other measures to delay the progression of chronic kidney disease, the vigorous management of cardiovascular risk factors and finally, the treatment of advanced chronic kidney disease and its consequences. These topics are briefly reviewed in the present paper, with particular emphasis on the recent progresses in antiproteinuric treatment.
Jadoul
M
M
Cliniques Universitaires St Luc, Department of Nephrology, Université Catholique de Louvain, Brussels, Belgium. jadoul@nefr.ucl.ac.be
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy; D018450:Disease Progression; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D008181:Lupus Nephritis / Q000188:drug therapy*; D005791:Patient Care; D011507:Proteinuria / Q000188:drug therapy* / Q000209:etiology; D012307:Risk Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002317:Cardiovascular Agents; D007166:Immunosuppressive Agents